Infectious disease physician Dr. Marcel Curlin joins pharmacy educator Dr. Jeff Goad to examine COVID-19's continued clinical burden, the mechanics of mRNA and protein-based vaccines, and the roots of ongoing vaccine hesitancy. The series equips pharmacists with practical, evidence-based language for guiding hesitant patients toward vaccination amid a shifting recommendation landscape.
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP; and Clipper F. Young, PharmD, MPH, CDCES, BC-ADM, BCGP, APh, FADCES, discuss how hypercortisolism is often underdiagnosed in patients with difficult-to-control type 2 diabetes, with the CATALYST study revealing a surprising 23.8% prevalence rate, and emphasize the critical role pharmacists can play in screening patients who require multiple medications yet still have poor glycemic and blood pressure control.
Lucio Volino, PharmD, FAPhA, RUCIF, NCNTT, and Lauren Angelo, PharmD, MBA, discuss how recent CDC recommendations have lowered the age for routine pneumococcal vaccination from 65 to 50 years old, explore the complexities of vaccine selection and sequencing among different pneumococcal vaccines (PCV15, PCV20, PCV21, and PPSV23), and provide practical guidance for pharmacists on identifying eligible patients, overcoming vaccination barriers, and implementing systematic approaches to improve pneumococcal vaccination rates in adult populations.
A panel of experts discuss current standard of care and treatment options for treatment-resistant depression.
Current treatment and patient education strategies are discussed by Jerry Meece, RPh, CDCES, FACA, FADCES, and Jennifer D. Goldman, RPh, PharmD, CDCES, BC-ADM, FCCP.
An expert panel discusses the importance of accessibility, patient engagement and adherence to receiving yearly influenza vaccines.
A panel of experts discuss opioid abuse in today’s treatment landscape for pain management and the ways to counteract it, focusing on naloxone.
Recommendations for counseling and managing patients’ lipid levels with newer treatments as prophylaxis against cardiovascular events.
